Arthritis Research Funds Debated in Secret Virtual Session
Published Date: 3/25/2025
Notice
Summary
The National Institute of Arthritis and Musculoskeletal and Skin Diseases is holding a closed virtual meeting from April 30 to May 1, 2025, to review grant applications for small business research projects. This meeting affects researchers and small businesses seeking funding in musculoskeletal, rheumatic, and skin sciences. No public access is allowed to protect private and sensitive information, and the decisions could impact future research funding.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 0 costs, 1 mixed.
SBIR Grant Applications Reviewed
The NIH will hold a closed virtual panel on April 30–May 1, 2025, to review and evaluate SBIR grant applications for musculoskeletal, rheumatic, and skin sciences. This meeting directly affects researchers and small businesses who applied for this funding because the panel’s decisions could determine which projects receive research grants.
Applicant Confidentiality Secured
The meeting will be closed to the public under 5 U.S.C. 552b(c)(4) and (c)(6) to protect confidential trade secrets, patentable material, and personal information tied to grant applications. If you applied, your commercial details and personal data will not be publicly disclosed during this April 30–May 1, 2025 review.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16683, Proposed Collection; 60-Day Comment Request; Data Use Certification for the NIH National Institute on Drug Abuse Data Share Site
The purpose of this notice is to inform the public of the information collection requirement for the NIDA Data Share, the data use terms and conditions, and to request a progress report statement at the time of renewal. In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-16544, Government-Owned Inventions; Availability for Licensing
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing to achieve expeditious commercialization of results of federally-funded research for the benefit of the public health.
2026-16440, NIH Owned Invention Available for License: Soluble Tissue Factor, a Novel Target, and Antibodies, for Diagnosis, Prevention and Treatment of Thrombosis and Related Conditions
Scientists at the National Cancer Institute (NCI) have discovered a novel therapeutic, diagnostic and prognostic target for thrombosis: Soluble Tissue Factor (sTF). NCI has generated first-in- class antibodies and platform selectively neutralizing pathological coagulation while preserving normal hemostasis. This platform technology can be used to prevent, diagnose and treat pathological thrombosis caused by a variety of clinical conditions-including cancer, sepsis, infectious diseases (e.g., COVID), autoimmune disorders, trauma, heart conditions and inflammatory conditions. It offers a much more sensitive and specific test of thrombosis than the current D-dimer test. It may be applicable to any clinical condition which induces necroptosis, pyroptosis and NETtosis, such as cancer, neurodegenerative disease, ischemia-reperfusion and acute injuries, traumatic injuries, bacterial and viral infections, cardiovascular conditions, and atherosclerosis, inflammatory, autoimmune conditions, and others.
2026-16071, Proposed Collection; 60-Day Comment Request: The Impact of Clinical Research Training and Medical Education at the Clinical Center on Physician Careers in Academia and Clinical Research (Clinical Center)
In compliance with the requirement of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the Clinical Center, the National Institutes of Health (NIH) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-15565, Proposed Collection; 60-Day Comment Request, Data Use Certification for the NIH Brain Development Cohorts (NBDC) Data Hub, (National Institute on Drug Abuse)
In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. The purpose of this revision is to update instructions for the Research Data Use Statement and the Progress Report, and to add new instructions for attesting to National Institute of Standards & Technology (NIST) security compliance, and for a Project Close-out at the time of project completion. Burden levels remain unchanged.
2026-14964, Center for Scientific Review; Notice of Closed Meeting
The Center for Scientific Review is holding a closed virtual meeting on August 19, 2026, to review neuroscience career development grant applications. This meeting is private to protect sensitive info like trade secrets and personal details. Researchers applying for these grants should note the date, as funding decisions could impact their projects and careers.
Previous / Next Documents
Previous: 2025-04966, Marlow Hydro LLC; Notice Soliciting Scoping Comments
Marlow Hydro LLC wants to build a small hydroelectric project on the Ashuelot River in Marlow, New Hampshire. The government is asking the public to share their thoughts by April 17, 2025, before deciding on the project. This could bring clean energy to the area, but folks have a chance to speak up early in the process.
Next: 2025-04968, National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Meeting
The National Institute of Arthritis and Musculoskeletal and Skin Diseases is holding a public meeting on April 21, 2025, to review grant applications and discuss important updates. Researchers, patients, and the public can join online or in person, with special accommodations available. This meeting helps decide funding for new research projects that could lead to better treatments and care.